C3ai Inc
3 nominees · 3 ballot items.
Election of three Class II directors; advisory approval of the compensation of our named executive officers; and ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2026.
Follow how the vote landed and what changed on C3ai Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors (Class II
ManagementBoard: FORElection of three Class II director nominees: General (Ret.) John Hyten, Richard C. Levin, and Bruce Sewell, to serve three-year terms.
- 2
Advisory Approval of Named Executive Officer Compensation
ManagementBoard: FORAdvisory vote on the compensation of the named executive officers as disclosed in this proxy statement (say-on-pay).
- 3
Ratification of Deloitte & Touche LLP as Independent Registered Public Accounting Firm
ManagementBoard: FORRatification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending April 30, 2026.
Nominees on the ballot3
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.5% | 8,544,184 | $72M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 3.8% | 5,840,704 | $49M |
| 3 | BlackRock, Inc. | 3.3% | 5,119,387 | $43M |
| 4 | BlackRock, Inc. | 3.0% | 4,608,799 | $39M |
| 5 | GOLDMAN SACHS GROUP INC | 2.4% | 3,697,195 | $31M |
| 6 | MORGAN STANLEY | 2.1% | 3,240,414 | $27M |
| 7 | STATE STREET CORP | 2.0% | 3,150,583 | $27M |
| 8 | MILLENNIUM MANAGEMENT LLC | 1.8% | 2,848,762 | $24M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 2,485,851 | $21M |
| 10 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 1.5% | 2,323,738 | $20M |
Other Technology sector meetings6
Upcoming shareholder meetings at C3ai Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the C3ai Inc 2025 annual meeting?
- C3ai Inc (AI) holds its 2025 annual shareholder meeting on Friday, October 3, 2025.
- What is the record date for the C3ai Inc 2025 meeting?
- The record date for the C3ai Inc 2025 meeting is Monday, August 4, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for C3ai Inc's 2025 meeting?
- The board is presenting 3 director nominees at the C3ai Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the C3ai Inc 2025 meeting?
- Shareholders will vote on 3 proposals at the C3ai Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.